Qiagen and KingMed to Offer HPV Test in China

Qiagen, the Dutch provider of sample and assay technologies, will co-market its digene HPV (human papillomavirus) Test in China with KingMed Diagnostics, the largest independent chain of laboratory services in China. KingMed will function as a centralized lab, collecting tests from rural areas and smaller hospitals for processing and analysis. Qiagen positioned the agreement as way to increase the penetration of its molecular diagnostics business in China. More details.... Stock Symbol: (NSDQ: QGEN) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});